Role of GENEXpert MTB/RIF in the Diagnosis of Tuberculosis Experience of the Central Laboratory of CHU Hassan II in Fez

Introduction Tuberculosis (TB) remains a major infectious disease, causing millions of deaths annually. The GeneXpert MTB/RIF, based on real-time PCR, provides rapid and reliable diagnosis while also detecting rifampicin resistance. Materials and Methods : This article presents the experience of the central laboratory at CHU Hassan II in Fez in diagnosing tuberculosis over a 12-month period, from December 2023 to December 2024. Results Among 507 samples, 65 (12.8%) were TB-positive. The majority were sputum samples (53.8%), followed by cerebrospinal fluid and peritoneal fluid. No rifampicin resistance was detected. Conclusion The GeneXpert MTB/RIF is a high-performance tool with elevated sensitivity, including in extrapulmonary TB. Its implementation enables faster diagnosis and improved patient management.

Authors

Publication Details

Journal
Journal of medical and dental science research.
Published
2025-04-01
DOI
https://doi.org/10.35629/076x-12041821
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Role of GENEXpert MTB/RIF in the Diagnosis of Tuberculosis Experience of the Central Laboratory of CHU Hassan II in Fez

Ghita Yahyaoui, Sara Kouara, Mustapha Mahmoud, Braoul Michkate Braoul Michkate et al.
Journal of medical and dental science research.
Tuberculosis Research and Epidemiology
article

Role of GENEXpert MTB/RIF in the Diagnosis of Tuberculosis Experience of the Central Laboratory of CHU Hassan II in Fez

Ghita Yahyaoui, Sara Kouara, Mustapha Mahmoud, Braoul Michkate Braoul Michkate, Raounak El Yaacoubi Raounak El Yaacoubi
article en

Abstract

Introduction Tuberculosis (TB) remains a major infectious disease, causing millions of deaths annually. The GeneXpert MTB/RIF, based on real-time PCR, provides rapid and reliable diagnosis while also detecting rifampicin resistance. Materials and Methods : This article presents the experience of the central laboratory at CHU Hassan II in Fez in diagnosing tuberculosis over a 12-month period, from December 2023 to December 2024. Results Among 507 samples, 65 (12.8%) were TB-positive. The majority were sputum samples (53.8%), followed by cerebrospinal fluid and peritoneal fluid. No rifampicin resistance was detected. Conclusion The GeneXpert MTB/RIF is a high-performance tool with elevated sensitivity, including in extrapulmonary TB. Its implementation enables faster diagnosis and improved patient management.

Journal of medical and dental science research.Vol. 12(4)
Openalex Percentile: Top 87%
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Role of GENEXpert MTB/RIF in the Diagnosis of Tuberculosis Experience of the Central Laboratory of CHU Hassan II in Fez — Ghita Yahyaoui, Sara Kouara, et al. · Journal of medical and dental science research. (2025) | TGRS Research Map | TGRS